Clinical Trials Logo

Clinical Trial Summary

This research will confirm that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic effect of these patients.


Clinical Trial Description

1. Confirmed that Pcv-aCO2 is suitable for the guidance of early fluid therapy and the evaluation of the prognosis of patients with abnormal hemodynamics after abdominal tumor surgery, and is expected to be a new monitoring index to improve the therapeutic efficacy of this kind of patients.

2. Pcv-aCO2 effectively reflected the improvement of tissue and organ microcirculation disorder through the individual goal target treatment to guide the fluid resuscitation in the hemodynamic instability patients.

3. Research of the correlation between Pcv-aCO2 and the organ function in patients with abnormal hemodynamics after operation. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02977429
Study type Interventional
Source Tianjin Medical University Cancer Institute and Hospital
Contact Yang Yang, physician
Phone 022-23340123
Email yyicu3021@126.com
Status Recruiting
Phase N/A
Start date October 2016
Completion date September 2018

See also
  Status Clinical Trial Phase
Completed NCT01250574 - Neutrophil CD64 and Procalcitonin as Novel Biomarkers for Postoperative Infections
Recruiting NCT02191475 - Effect Study of Tigecycline to Treat Severe Sepsis and Septic Shock Phase 2/Phase 3
Recruiting NCT03090334 - A B-D-Glucan Driven Antifungal Stewardship Approach for Invasive Candidiasis N/A
Recruiting NCT03163095 - Closed or Open Abdomen for the Management of Abdominal Sepsis N/A
Not yet recruiting NCT04903886 - Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
Completed NCT02168946 - Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults Phase 3
Completed NCT01414959 - Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients N/A
Recruiting NCT03815370 - A Non-Traumatic Binder for Temporary Abdominal Wall Closure N/A